Introducing transcription factors to multipotent mesenchymal stem cells: Making transdifferentiation possible

Stem Cells

Volumn 27, Issue 10, 2009, Pages 2509-2515

  Barzilay, Ran ^a   Melamed, Eldad ^a   Offen, Daniel ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adult stem cells; Gene delivery systems in vivo or in vitro; Lineage conversion; Mesenchymal stem cells; Reprogramming; Stem cell plasticity; Transdifferentiation

Indexed keywords

TRANSCRIPTION FACTOR;

AUTOTRANSPLANTATION; CELL DIFFERENTIATION; CELL FATE; CELL ISOLATION; CELL LINEAGE; CELL TRANSDIFFERENTIATION; GENE EXPRESSION REGULATION; HUMAN; LYMPHOCYTE TRANSFORMATION; MACROPHAGE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL;

ANIMALS; CELL LINEAGE; CELL TRANSDIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MOLECULAR BIOLOGY; MULTIPOTENT STEM CELLS; PHENOTYPE; TRANSCRIPTION FACTORS;

EID: 70350243075     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.172     Document Type: Review

References (119)

1. Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 1986;45: 917-927.
2. Vormoor J, Lapidot T, Pflumio F et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994;83:2489-2497. (Pubitemid 24135840)
3. Gage FH. Mammalian neural stem cells. Science 2000;287: 1433-1438.
4. Lavker RM, Sun TT. Epidermal stem cells: Properties, markers, and location. Proc Natl Acad Sci USA 2000;97:13473-13475.
5. Hausman GJ, Campion DR, Martin RJ. Search for the adipocyte precursor cell and factors that promote its differentiation. J Lipid Res 1980;21:657-670.
6. Miller JB, Schaefer L, Dominov JA. Seeking muscle stem cells. Curr Top Dev Biol 1999;43:191-219.
7. Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-1757. (Pubitemid 32497029)
8. Duret C, Gerbal-Chaloin S, Ramos J et al. Isolation, characterization, and differentiation to hepatocyte-like cells of nonparenchymal epithelial cells from adult human liver. Stem Cells 2007;25: 1779-1790. (Pubitemid 47121857)
9. Bussolati B, Bruno S, Grange C et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol 2005;166:545-555. (Pubitemid 40189050)
10. Bjornson CR, Rietze RL, Reynolds BA et al. Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999;283:534-537. (Pubitemid 129504619)
11. Galli R, Borello U, Gritti A et al. Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 2000;10:986-991. (Pubitemid 30749197)
12. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418: 41-49. (Pubitemid 34742565)
13. Joannides A, Gaughwin P, Schwiening C et al. Efficient generation of neural precursors from adult human skin: Astrocytes promote neurogenesis from skin-derived stem cells. Lancet 2004;364: 172-178. (Pubitemid 38891689)
14. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295. (Pubitemid 35471185)
15. Alessandri G, Pagano S, Bez A et al. Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 2004;364:1872-1883. (Pubitemid 39536091)
16. Kögler G, Sensken S, Airey JA et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004;200:123-135. (Pubitemid 38982172)
17. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976;4:267-274.
18. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147. (Pubitemid 29282067)
19. Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood 2003;102:3483-3493.
20. Tang DQ, Cao LZ, Burkhardt BR et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004;53:1721-1732.
21. Sato Y, Araki H, Kato J et al. Human mesenchymal stem cells xeno-grafted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005;106:756-763. (Pubitemid 40981278)
22. Toma C, Pittenger MF, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-98. (Pubitemid 34049148)
23. Phinney DG. Biochemical heterogeneity of mesenchymal stem cell populations: Clues to their therapeutic efficacy. Cell Cycle 2007;6: 2884-2889.
24. Phinney DG, Prockop DJ. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007;25:2896-2902.
25. Xie H, Ye M, Feng R et al. Stepwise reprogramming of B cells into macrophages. Cell 2004;117:663-676.
26. Laiosa CV, Stadtfeld M, Xie H et al. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBPα and PU.1 transcription factors. Immunity 2006;25:731-744. (Pubitemid 46107288)
27. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
28. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872. (Pubitemid 350138099)
29. Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 2008;9:725-729.
30. Chen Y, Teng FY, Tang BL. Coaxing bone marrow stromal mesenchymal stem cells towards neuronal differentiation: Progress and uncertainties. Cell Mol Life Sci 2006;63:1649-1657. (Pubitemid 44252178)
31. Phinney DG, Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des 2005;11: 1255-1265. (Pubitemid 40458271)
32. Krabbe C, Zimmer J, Meyer M. Neural transdifferentiation of mesenchymal stem cells - a critical review. APMIS 2005;113:831-844. (Pubitemid 43934224)
33. Ortiz-Gonzalez XR, Keene CD, Verfaille CM et al. Neural induction of adult bone marrow and umbilical cord stem cells. Curr Neurovasc Res 2004;1:207-213.
34. Barzilay R, Levy YS, Melamed E et al. Adult stem cells for neuronal repair. Isr Med Assoc J 2006;8:61-66. (Pubitemid 43116072)
35. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? Nat Med 2001;7:393-395.
36. Lu P, Blesch A, Tuszynski MH. Induction of bone marrow stromal cells to neurons: Differentiation, transdifferentiation, or artifact? J Neurosci Res 2004;77:174-191. (Pubitemid 38859403)
37. Neuhuber B, Gallo G, Howard L et al. Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: Disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J Neurosci Res 2004;77:192-204. (Pubitemid 38859404)
38. Croft AP, Przyborski SA. Formation of neurons by non-neural adult stem cells: Potential mechanism implicates an artifact of growth in culture. Stem Cells 2006;24:1841-1851.
39. Brazelton TR, Rossi FMV, Keshet GI et al. From marrow to brain: Expression of neuronal phenotypes in adult mice. Science 2000;290: 1775-1779. (Pubitemid 32004810)
40. Mezey E, Chandross KJ, Harta G et al. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000;290:1779-1782. (Pubitemid 32004811)
41. Mezey E, Key S, Vogelsang G et al. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci USA 2003; 100:1364-1369. (Pubitemid 36184007)
42. Weimann JM, Johansson CB, Trejo A et al. Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat Cell Biol 2003;5:959-966. (Pubitemid 37406908)
43. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003;422:901-904. (Pubitemid 36520043)
44. Wang X, Willenbring H, Akkari Y et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003;422: 897-901. (Pubitemid 36520042)
45. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003;425:968-973. (Pubitemid 37376928)
46. Blondheim NR, Levy YS, Ben-Zur T et al. Human mesenchymal stem cells express neural genes, suggesting a neural predisposition. Stem Cells Dev 2006;15:141-164. (Pubitemid 43726495)
47. Deng J, Petersen BE, Steindler DA et al. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells 2006;24:1054-1064. (Pubitemid 44464738)
48. Minguell JJ, Fierro FA, Epuñan MJ et al. Nonstimulated human uncommitted mesenchymal stem cells express cell markers of mesenchymal and neural lineages. Stem Cells Dev 2005;14:408-414. (Pubitemid 41243704)
49. Montzka K, Lassonczyk N, Tschöke B et al. Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: Misleading marker gene expression. BMC Neurosci 2009;10:16.
50. Tondreau T, Lagneaux L, Dejeneffe M et al. Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation 2004;72:319-326. (Pubitemid 41702124)
51. Wislet-Gendebien S, Hans G, Leprince P et al. Plasticity of cultured mesenchymal stem cells: Switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 2005;23:392-402. (Pubitemid 40404458)
52. Cho KJ, Trzaska KA, Greco SJ et al. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1α. Stem Cells 2005;23:383-391.
53. Tropel P, Platet N, Platel JC et al. Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. Stem Cells 2007; 25:2868-2876.
54. + channel types. Exp Hematol 2006;34: 1563-1572.
55. Greco SJ, Zhou C, Ye JH et al. An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev 2007;16:811-826. (Pubitemid 350125224)
56. Fu L, Zhu L, Huang Y et al. Derivation of neural stem cells from mesenchymal stem cells: Evidence for a bipotential stem cell population. Stem Cells Dev 2008;17:1109-1121.
57. Tondreau T, Dejeneffe M, Meuleman N et al. Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells. BMC Genomics 2008;9:166. (Pubitemid 351611895)
58. Tao H, Rao R, Ma DDF. Cytokine-induced stable neuronal differentiation of human bone marrow mesenchymal stem cells in a serum/feeder cell-free condition. Dev Growth Differ 2005;47:423-433. (Pubitemid 41355197)
59. Zurita M, Vaquero J, Oya S et al. Neurotrophic Schwann-cell factors induce neural differentiation of bone marrow stromal cells. Neuroreport 2007;18:1713-1717. (Pubitemid 47549140)
60. Bossolasco P, Cova L, Calzarossa C et al. Neuro-glial differentiation of human bone marrow stem cells in vitro. Exp Neurol 2005;193: 312-313. (Pubitemid 40616181)
61. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8: 315-317.
62. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-1166. (Pubitemid 30229533)
63. Song SU, Kim CS, Yoon SP et al. Variations of clonal marrow stem cell lines established from human bone marrow in surface epitopes, differentiation potential, gene expression, and cytokine secretion. Stem Cells Dev 2008;17:451-461.
64. Nagoshi N, Shibata S, Kubota Y et al. Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell 2008;2:392-403.
65. Takashima Y, Era T, Nakao K et al. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007;129: 1377-1388. (Pubitemid 46970707)
66. Chang HH, Hemberg M, Barahona M et al. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 2008;453:544-547. (Pubitemid 351733323)
67. Graf T, Stadtfeld M. Heterogeneity of embryonic and adult stem cells. Cell Stem Cell 2008;3:480-483.
68. Yamazaki K, Allen TD. Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: The "neuro-reticular complex." Am J Anat 1990;187:261-276.
69. Phillips MI, Tang YL. Genetic modification of stem cells for transplantation. Adv Drug Deliv Rev 2008;60:160-172. (Pubitemid 350236397)
70. Conrad C, Gupta R, Mohan H et al. Genetically engineered stem cells for therapeutic gene delivery. Curr Gene Ther 2007;7:249-260. (Pubitemid 47232957)
71. Li Y, Zhang R, Qiao H et al. Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells. J Cell Physiol 2007;211:36-44. (Pubitemid 46363894)
72. Kim SS, Yoo SW, Park TS et al. Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells 2008;26:2217-2228.
73. Hedlund E, Pruszak J, Ferree A et al. Selection of embryonic stem cell-derived enhanced green fluorescent protein-positive dopamine neurons using the tyrosine hydroxylase promoter is confounded by reporter gene expression in immature cell populations. Stem Cells 2007;25:1126-1135. (Pubitemid 46684872)
74. Hedlund E, Pruszak J, Lardaro T et al. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 2008;26: 1526-1536.
75. Nair V. Retrovirus-induced oncogenesis and safety of retroviral vectors. Curr Opin Mol Ther 2008;10:431-438.
76. Hellmann MA, Panet H, Barhum Y et al. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett 2006;395:124-128. (Pubitemid 43188877)
77. Chamberlain G, Fox J, Ashton B et al. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25: 2739-2749. (Pubitemid 350127858)
78. McMahon JM, Conroy S, Lyons M et al. Gene transfer into rat mesenchymal stem cells: A comparative study of viral and nonviral vectors. Stem Cells Dev 2006;15:87-96.
79. Clements MO, Godfrey A, Crossley J et al. Lentiviral manipulation of gene expression in human adult and embryonic stem cells. Tissue Eng 2006;12:1741-1751. (Pubitemid 44162834)
80. Van Damme A, Thorrez L, Ma L et al. Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Stem Cells 2006;24:896-907. (Pubitemid 44464723)
81. Kallifatidis G, Beckermann BM, Groth A et al. Improved lentiviral transduction of human mesenchymal stem cells for therapeutic intervention in pancreatic cancer. Cancer Gene Ther 2008;15: 231-240.
82. Gordon D, Glover CP, Merrison AM et al. Enhanced green fluorescent protein-expressing human mesenchymal stem cells retain neural marker expression. J Neuroimmunol 2008;193:59-67.
83. Zhang XY, La Russa VF, Bao L et al. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol Ther 2002;5:555-565. (Pubitemid 34546085)
84. Ricks DM, Kutner R, Zhang XY et al. Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev 2008;17:441-450. (Pubitemid 351948200)
85. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006;441:1068-1074. (Pubitemid 43990718)
86. Zipori D. The stem state: Plasticity is essential, whereas self-renewal and hierarchy are optional. Stem Cells 2005;23:719-726. (Pubitemid 40791787)
87. Zipori D. The stem state: Mesenchymal plasticity as a paradigm. Curr Stem Cell Res Ther 2006;1:95-102.
88. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317. (Pubitemid 47080336)
89. Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448: 318-324.
90. Aoi T, Yae K, Nakagawa M et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008;321: 699-702.
91. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
92. Lowry WE, Richter L, Yachechko R et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 2008;105:2883-2888. (Pubitemid 351723638)
93. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146.
94. Hanna J, Markoulaki S, Schorderet P et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008;133:250-264.
95. Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic β cells into induced pluripotent stem cells. Curr Biol 2008; 18:890-894.
96. Blelloch R, Venere M, Yen J et al. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 2007;1: 245-247. (Pubitemid 47355331)
97. Eminli S, Utikal J, Arnold K et al. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 2008;26:2467-2474.
98. Kim JB, Zaehres H, Wu G et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008;454:646-650.
99. Hanna J, Wernig M, Markoulaki S et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007;318:1920-1923.
100. Wernig M, Zhao JP, Pruszak J et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain, improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 2008;105:5856-5861. (Pubitemid 351758462)
101. Park IH, Arora N, Huo H et al. Disease-specific induced pluripotent stem cells. Cell 2008;134:877-886.
102. Dimos JT, Rodolfa KT, Niakan KK et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321:1218-1221.
103. Hochedlinger K, Plath K. Epigenetic reprogramming and induced pluripotency. Development 2009;136:509-523.
104. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324: 797-801.
105. Okita K, Nakagawa M, Hyenjong H et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322:949-953.
106. Woltjen K, Michael IP, Mohseni P et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009;458:766-770.
107. Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4: 381-384.
108. Shen M, Yoshida E, Yan W et al. Basic helix-loop-helix protein DEC1 promotes chondrocyte differentiation at the early and terminal stages. J Biol Chem 2002;277:50112-50120. (Pubitemid 36014464)
109. Iwata T, Kawamoto T, Sasabe E et al. Effects of overexpression of basic helix-loop-helix transcription factor Dec1 on osteogenic and adipogenic differentiation of mesenchymal stem cells. Eur J Cell Biol 2006;85:423-431.
110. Zha YH, He JF, Mei YW et al. Zinc-finger transcription factor Snail accelerates survival, migration and expression of matrix metalloproteinase- 2 in human bone mesenchymal stem cells. Cell Biol Int 2007;31:1089-1096.
111. Ben-Shoshan J, Schwartz S, Luboshits G et al. Constitutive expression of HIF-1α and HIF-2α in bone marrow stromal cells differentially promote their proangiogenic properties. Stem Cells 2008;26: 2634-2643.
112. Karnieli O, Izhar-Prato Y, Bulvik S et al. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 2007;25:2837-2844. (Pubitemid 350127868)
113. Yang Y, Li Y, Lv Y et al. NRSF silencing induces neuronal differentiation of human mesenchymal stem cells. Exp Cell Res 314: 2257-2265.
114. Trzaska KA, Reddy BY, Munoz JL et al. Loss of RE-1 silencing factor in mesenchymal stem cell-derived dopamine progenitors induces functional maturity. Mol Cell Neurosci 2008;39:285-290.
115. Barzilay R, Ben-Zur T, Bulvik S et al. Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells. Stem Cells Dev 2009;18:591-601.
116. Andersson E, Tryggvason U, Deng Q et al. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 2006;124:393-405. (Pubitemid 43121986)
117. Friling S, Andersson E, Thompson LH et al. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci USA 2009;106:7613-7618.
118. Zhou Q, Brown J, Kanarek A et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008;455:627-632.
119. Condic ML, Rao M. Regulatory issues for personalized pluripotent cells. Stem Cells 2008;26:2753-2758.